Notifications

Home

Stocks
- Stock Screener
- Market Movers
- Insider Trades
- Upcoming Earnings
- Upcoming Dividends
Options
- Unusual Options Activity
- Implied Volatility Rank
- Volatility %Change
News
Upcoming IPOs

Allarity Therapeutics Inc (ALLR)

$0.91 -0.05 (-5.00%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	14.45M
Revenue (ttm)	0.00
Net Income (ttm)	-24.52M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.07

Volume	742,500
Avg Vol	432,500
Day's Range	N/A - N/A
Shares Out	15.08M
Stochastic %K	22%
Beta	0.08
Analysts	Sell
Price Target	$9.00

Company Profile

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing novel anti-cancer therapeutics for patients with unmet medical needs. The company develops drugs for the personalized treatment of cancer using drug specific companion diagnostics generated by its proprietary drug response predictor technology. Its lead drug candidate includes Stenoparib, a novel dual inhibitor of poly-ADP-ribose polymerase (PARP1/2) that is being evaluated in a phase 2...

Industry: Biotechnology

Sector: Healthcare

Phone: 401 426 4664

Website: www.allarity.com

Address:

24 School Street, 2nd Floor, Boston, United States

ABUSAMR Aug. 18 at 8:40 PM

$ALLR SUNDAY NIGHT VS. MONDAY CLOSE

1 · Reply

ABUSAMR Aug. 18 at 8:37 PM

$ALLR @Nymn Do you remember that🤣🤣🤣🤣

0 · Reply

somaopp Aug. 18 at 8:01 PM

$ALLR low mid 0.80s or lower by eow??

0 · Reply

Wealthier Aug. 18 at 7:49 PM

$ALLR I just took a position. Everything I buy goes up and up. You’re welcome.

0 · Reply

Nymn Aug. 18 at 7:37 PM

$ALLR just another meh day. nothing to get worked up about. stay the course and the reward will come👍

0 · Reply

ACInvestorBlog Aug. 18 at 6:44 PM

$ALLR trading significantly below cash levels + buyback program in place. It should be trading well abv $2 imho

2 · Reply

somaopp Aug. 18 at 6:37 PM

$ALLR could close in the 0.80s??

0 · Reply

ACInvestorBlog Aug. 18 at 5:22 PM

$ALLR lets see if it regains the $1 price level before the close. I still liking this name. It seems undervalued imho

1 · Reply

Nymn Aug. 18 at 5:00 PM

$ALLR still at .90?? lol easy hold. $5 min for me 👍

1 · Reply

ikkydiphoenix Aug. 18 at 4:52 PM

$ALLR i've been placing an order at 0.85 for over a month, executed today eventually. I may consider buying more if it goes lower.

1 · Reply

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships

Jul 15, 2025, 8:00 AM EDT - 4 weeks ago

Allarity Therapeutics Announces New Licensing and Laboratory Services Agreement to Expand DRP® Platform Utilization

Jul 7, 2025, 8:00 AM EDT - 6 weeks ago

Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer

Jun 27, 2025, 8:00 AM EDT - 7 weeks ago

Allarity Therapeutics Announces Dosing of Second Patient in New Phase 2 Trial of Stenoparib in Advanced Ovarian Cancer

Jun 11, 2025, 4:05 PM EDT - 2 months ago

Allarity Therapeutics Announces Changes to Board of Directors

May 9, 2025, 4:05 PM EDT - 3 months ago

Allarity Therapeutics Provides First Quarter 2025 Update, Highlighting Continued Stenoparib Benefit and Upcoming Trial Enrollment

Apr 14, 2025, 9:04 AM EDT - 4 months ago

ALLR Shareholders are Encouraged to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm

Mar 14, 2025, 4:30 AM EDT - 5 months ago

ALLR Investors Have Opportunity to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm

Mar 13, 2025, 8:30 AM EDT - 5 months ago

Allarity Therapeutics Announces Final Settlement with the U.S. Securities and Exchange Commission

Mar 6, 2025, 8:00 AM EST - 5 months ago

Allarity Therapeutics Announces Phase 2 Trial of Stenoparib in Combination with Temozolomide for Recurrent Small Cell Lung Cancer Fully Funded by the US Veterans Administration

Feb 24, 2025, 8:00 AM EST - 6 months ago

Allarity Therapeutics to Begin Enrollment for New Phase 2 Protocol to Advance Stenoparib Toward FDA Approval in Advanced Ovarian Cancer Patients

Feb 14, 2025, 10:00 AM EST - 6 months ago

Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Feb 13, 2025, 10:00 AM EST - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Allarity Therapeutics, Inc. (ALLR) Shareholders to Inquire about Securities Investigation

Feb 12, 2025, 10:00 AM EST - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Allarity Therapeutics, Inc. (ALLR) And Encourages Shareholders to Connect

Feb 11, 2025, 10:00 AM EST - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Allarity Therapeutics, Inc. (ALLR) And Encourages Shareholders to Reach Out

Feb 10, 2025, 10:00 AM EST - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Allarity Therapeutics, Inc. (ALLR) Stockholders to Inquire about Securities Investigation

Feb 9, 2025, 10:00 AM EST - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Allarity Therapeutics, Inc. (ALLR) and Encourages Investors to Learn More About the Investigation

Feb 7, 2025, 10:00 AM EST - 6 months ago

Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Feb 6, 2025, 10:00 AM EST - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Allarity Therapeutics, Inc. (ALLR) And Encourages Investors to Connect

Feb 6, 2025, 8:00 AM EST - 6 months ago

Allarity Therapeutics Announces Expansion of Phase 2 Clinical Trial to Accelerate Development of Stenoparib in Advanced Ovarian Cancer

Feb 4, 2025, 10:00 AM EST - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Allarity Therapeutics, Inc. (ALLR) Investors to Inquire about Securities Investigation

Feb 3, 2025, 10:00 AM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Allarity Therapeutics, Inc. (ALLR) And Encourages Investors to Reach Out

Feb 2, 2025, 10:00 AM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Allarity Therapeutics, Inc. (ALLR) And Encourages Stockholders to Reach Out

Jan 31, 2025, 10:00 AM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Allarity Therapeutics, Inc. (ALLR) And Encourages Stockholders to Connect

Jan 30, 2025, 8:00 AM EST - 7 months ago

Allarity Therapeutics Announces Filing of Form 8-K Regarding Settlement Agreement in Principle with SEC

Jan 8, 2025, 10:00 AM EST - 7 months ago

Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Jan 5, 2025, 10:00 AM EST - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Allarity Therapeutics, Inc. (ALLR) and Encourages Stockholders to Learn More About the Investigation

Nov 18, 2024, 8:00 AM EST - 9 months ago

Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements

Nov 11, 2024, 3:45 PM EST - 10 months ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics

Nov 11, 2024, 11:15 AM EST - 10 months ago

DEADLINE TOMORROW: Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Investors Are Invited To Reach Out To The Schall Law Firm

Nov 9, 2024, 12:30 PM EST - 10 months ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Are Invited To Contact The Schall Law Firm

Nov 8, 2024, 7:00 PM EST - 10 months ago

ALLR Deadline: Rosen Law Firm Urges Allarity Therapeutics, Inc. (NASDAQ: ALLR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Nov 8, 2024, 9:45 AM EST - 10 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics

Nov 7, 2024, 11:00 AM EST - 10 months ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Should Contact The Schall Law Firm

Nov 6, 2024, 11:00 AM EST - 10 months ago

The Schall Law Firm Encourages Stockholder Participation In A Case Against Allarity Therapeutics, Inc. For Fraud

Nov 4, 2024, 11:00 AM EST - 10 months ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Are Urged To Help The Schall Law Firm

Nov 2, 2024, 11:00 AM EDT - 10 months ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Are Urged To Contact The Schall Law Firm

Oct 29, 2024, 11:00 AM EDT - 10 months ago

The Schall Law Firm Invites Stockholders To Join A Lawsuit Against Allarity Therapeutics, Inc. For Fraud

Oct 27, 2024, 11:00 AM EDT - 10 months ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Affected Investors Are Urged To Contact The Schall Law Firm

Oct 22, 2024, 8:00 AM EDT - 10 months ago

Allarity Therapeutics to be Granted European Patent for DRP® Companion Diagnostic for Stenoparib

ABUSAMR Aug. 18 at 8:40 PM

$ALLR SUNDAY NIGHT VS. MONDAY CLOSE

1 · Reply

ABUSAMR Aug. 18 at 8:37 PM

$ALLR @Nymn Do you remember that🤣🤣🤣🤣

0 · Reply

somaopp Aug. 18 at 8:01 PM

$ALLR low mid 0.80s or lower by eow??

0 · Reply

Wealthier Aug. 18 at 7:49 PM

$ALLR I just took a position. Everything I buy goes up and up. You’re welcome.

0 · Reply

Nymn Aug. 18 at 7:37 PM

$ALLR just another meh day. nothing to get worked up about. stay the course and the reward will come👍

0 · Reply

ACInvestorBlog Aug. 18 at 6:44 PM

$ALLR trading significantly below cash levels + buyback program in place. It should be trading well abv $2 imho

2 · Reply

somaopp Aug. 18 at 6:37 PM

$ALLR could close in the 0.80s??

0 · Reply

ACInvestorBlog Aug. 18 at 5:22 PM

$ALLR lets see if it regains the $1 price level before the close. I still liking this name. It seems undervalued imho

1 · Reply

Nymn Aug. 18 at 5:00 PM

$ALLR still at .90?? lol easy hold. $5 min for me 👍

1 · Reply

ikkydiphoenix Aug. 18 at 4:52 PM

$ALLR i've been placing an order at 0.85 for over a month, executed today eventually. I may consider buying more if it goes lower.

1 · Reply

papibaro Aug. 18 at 3:53 PM

$ALLR $OPEN so you are gonna pump it and dump it like the last 3-4 times?

1 · Reply

ABUSAMR Aug. 18 at 3:34 PM

$ALLR I said that before, remember? You didn't believe me. Now I'll watch. Either the stock crashes or it rises.

1 · Reply

Nymn Aug. 18 at 2:51 PM

$ALLR not me, green is green sweetheart!!! never assume 😉😎

1 · Reply

Jimesica Aug. 18 at 2:44 PM

$ALLR https://seekingalpha.com/news/4486534-allarity-therapeutics-gaap-eps-of-0_15-beats-by-0_06

0 · Reply

ACInvestorBlog Aug. 18 at 2:29 PM

$OPEN What a beauty !! $ALLR is back into my buy zone ….

1 · Reply

somaopp Aug. 18 at 2:27 PM

$ALLR No milestone in the near future? could tank further..

0 · Reply

kingitalia Aug. 18 at 2:13 PM

$ALLR disaster stock... No words from a long investor

0 · Reply

Phaarson Aug. 18 at 2:01 PM

$ALLR who is the reeetard here? Haha

0 · Reply

Phaarson Aug. 18 at 1:55 PM

$ALLR get out before its to late, this boat take a lot of water in now.

0 · Reply

ka1954 Aug. 18 at 1:49 PM

$ALLR piece of crap every chance it gets

0 · Reply

Phaarson Aug. 18 at 1:48 PM

$ALLR now I have wait so long for the 0,7 and now we on the way.. but sold mostly of the short:/

0 · Reply

Phaarson Aug. 18 at 1:44 PM

$ALLR that’s a joke.

0 · Reply

1.0.0